Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | SELL | P14151 | 1/20 | 0.52 |
| ▸ | SELP | P16109 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.47 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.47 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30084375 | 1.00 | TSHR (0.54) | TSHRSELLSELPALDH1A1KDM4E | |
| Lithium Ion SCHEMBL31615947 | 0.89 | TSHR (0.44) | TSHRSELLSELPALDH1A1KDM4E | |
| SCHEMBL31615929 | 0.89 | TSHR (0.44) | TSHRSELLSELPALDH1A1KDM4E | |
| SCHEMBL18529852 | 0.86 | SELL (0.56) | TSHRSELLSELPALDH1A1KDM4E | |
| SCHEMBL10533170 | 0.84 | SELL (0.60) | TSHRSELLSELPALDH1A1KDM4E | |
| SCHEMBL4069345 | 0.82 | DPP4 (0.56) | TSHRSELLSELPALDH1A1KDM4E | |
| SCHEMBL2649879 | 0.82 | SELL (0.64) | TSHRSELLSELPALDH1A1KDM4E | |
| SCHEMBL29941520 | 0.82 | SELL (0.64) | TSHRSELLSELPALDH1A1KDM4E | |
| SCHEMBL29886586 | 0.81 | TSHR (0.64) | TSHRALDH1A1KDM4EHSD17B10MEN1 | |
| SCHEMBL432644 | 0.81 | TSHR (0.64) | TSHRALDH1A1KDM4EHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230157284-A1 | HIGH-LOAD SOLUTION CONCENTRATES OF DICAMBA | BASF CORPORATION | 2023-05-25 | — | — | US | claimed |
| US-20230148590-A1 | Aqueous Formulations of Dicamba | BASF CORPORATION | 2023-05-18 | — | — | US | claimed |
| EP-4132274-A1 | HIGH-LOAD SOLUTION CONCENTRATES OF DICAMBA | BASF Corporation (US) | 2023-02-15 | — | — | EP | claimed |
| EP-4125365-A1 | AQUEOUS FORMULATIONS OF DICAMBA | BASF Corporation (US) | 2023-02-08 | — | — | EP | claimed |
| CN-115426880-A | Aqueous formulations of dicamba | 巴斯夫公司 | 2022-12-02 | — | — | CN | claimed |
| CN-115361868-A | High-load solution concentrates of dicamba | 巴斯夫公司 | 2022-11-18 | — | — | CN | claimed |
| WO-2021198458-A1 | AQUEOUS FORMULATIONS OF DICAMBA | BASF CORPORATION (US) | 2021-10-07 | — | — | WO | claimed |
| CN-109761779-A | A kind of preparation method of 3,6- dichlorosalicylic acid and preparing the application in dicamba | 山东润博生物科技有限公司 | 2019-05-17 | — | — | CN | claimed |
| CN-109761802-A | A kind of preparation method of dicamba | 山东润博生物科技有限公司 | 2019-05-17 | — | — | CN | claimed |
| CN-109761794-A | A kind of salicylic complete alternation method in 3,6- dichlorosalicylic acid preparation process | 山东润博生物科技有限公司 | 2019-05-17 | — | — | CN | claimed |
| US-20120165511-A1 | PROTEIN PURIFICATION USING HCIC AND ION EXCHANGE CHROMATOGRAPHY | MEDAREX, INC. | 2012-06-28 | — | — | US | claimed |
| WO-2012015481-A1 | FUNCTIONAL BIODEGRADABLE POLYMERS | UNIVERSITY OF AKRON (US) | 2012-02-02 | — | — | WO | claimed |
| WO-2011031562-A1 | SYNTHETIC MYCOTOXIN ADSORBENTS AND METHODS OF MAKING AND UTILIZING THE SAME | ALLTECH, INC. (US) | 2011-03-17 | — | — | WO | claimed |
| US-20110054132-A1 | SYNTHETIC MYCOTOXIN ADSORBENTS AND METHODS OF MAKING AND UTILIZING THE SAME | ALLTECH, INC. (US) | 2011-03-03 | — | — | US | claimed |
| US-20090130739-A1 | Deactivation of mineral encapsulated nanobacteria | AMERICAN STERILIZER COMPANY (US) | 2009-05-21 | — | — | US | claimed |
| US-20090105465-A1 | Protein Purification Using HCIC and Ion Exchange Chromatography | MEDAREX, INC. (US) | 2009-04-23 | — | — | US | claimed |
| CN-101218247-A | Protein purification using HCIC and ion exchange chromatography | MEDAREX INC (US) | 2008-07-09 | — | — | CN | claimed |
| EP-1869067-A1 | PROTEIN PURIFICATION USING HCIC AMD ION EXCHANGE CHROMATOGRAPHY | Medarex, Inc. (US) | 2007-12-26 | — | — | EP | claimed |
| WO-2006110277-A1 | PROTEIN PURIFICATION USING HCIC AMD ION EXCHANGE CHROMATOGRAPHY | MEDAREX, INC. (US) | 2006-10-19 | — | — | WO | claimed |
| WO-1998050341-A1 | METHOD OF PREPARING SALICYLOYLAMINO ACIDS | EMISPHERE TECHNOLOGIES, INC. (US) | 1998-11-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230148590-A1 | Aqueous Formulations of Dicamba | BOLA2; BOLA2B, CIP2A, AQP1 | TSHR 4369/4885SELL 4718/4885SELP 3898/4885 |
| US-20230157284-A1 | HIGH-LOAD SOLUTION CONCENTRATES OF DICAMBA | PDHB, PDHA1, LDHB | TSHR 4408/4885SELL 3763/4885SELP 2298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.